Cisco TelePresence CE Version Control version-control exposure

| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.5 | $0-$5k | 0.00 |
Summary
A vulnerability described as very critical has been identified in Cisco TelePresence CE. This impacts an unknown function of the component Version Control. Executing a manipulation can lead to version-control exposure. This vulnerability appears as CVE-2022-20931. The attacker needs to be present on the local network. There is no available exploit. Upgrading the affected component is recommended.
Details
A vulnerability has been found in Cisco TelePresence CE (Unified Communication Software) (unknown version) and classified as very critical. This vulnerability affects an unknown code block of the component Version Control. The manipulation with an unknown input leads to a version-control exposure vulnerability. The CWE definition for the vulnerability is CWE-527. The product stores a CVS, git, or other repository in a directory, archive, or other resource that is stored, transferred, or otherwise made accessible to unauthorized actors. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
A vulnerability in the version control of Cisco TelePresence CE Software for Cisco Touch 10 Devices could allow an unauthenticated, adjacent attacker to install an older version of the software on an affected device. This vulnerability is due to insufficient version control. An attacker could exploit this vulnerability by installing an older version of Cisco TelePresence CE Software on an affected device. A successful exploit could allow the attacker to take advantage of vulnerabilities in older versions of the software.Cisco has released software updates that address this vulnerability. There are no workarounds that address this vulnerability.
The weakness was presented 10/06/2022 as cisco-sa-CTT-DAV-HSvEHHEt. The advisory is shared for download at tools.cisco.com. This vulnerability was named CVE-2022-20931. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 07/31/2025).
Upgrading eliminates this vulnerability.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.cisco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.7VulDB Meta Temp Score: 7.5
VulDB Base Score: 8.8
VulDB Temp Score: 8.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 6.5
CNA Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Version-control exposureCWE: CWE-527 / CWE-285 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Partially
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
11/02/2021 🔍10/06/2022 🔍
10/06/2022 🔍
07/31/2025 🔍
Sources
Vendor: cisco.comAdvisory: cisco-sa-CTT-DAV-HSvEHHEt
Status: Confirmed
CVE: CVE-2022-20931 (🔍)
GCVE (CVE): GCVE-0-2022-20931
GCVE (VulDB): GCVE-100-210208
Entry
Created: 10/06/2022 22:27Updated: 07/31/2025 22:39
Changes: 10/06/2022 22:27 (37), 10/30/2022 15:18 (1), 07/31/2025 22:39 (27)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.